Recent research highlights nicotinamide mononucleotide’s role in countering lung cell aging. NMN, a NAD+ precursor, shows potential in reversing senescence (the process of aging) in alveolar epithelial cells (AECs). These cells are essential for oxygen extraction and lung function. With aging, AECs enter a senescent state, impacting breathing abilities. The study focuses on how NMN …
More-
Nicotinamide Mononucleotide Shows Promise in Reducing Lung Cell Aging and Treating Pulmonary Fibrosis
-
New Research Manages to Control Liver Inflammation by Merging Nicotinamide Riboside Supplement with a Sirtuins Activator
Non-alcoholic fatty liver disease (NAFLD) is a terrible disease affecting many around the globe. The condition has a staggering prevalence of 30% worldwide. And that’s not all! Nearly 2 million people lose their battle against NAFLD each year globally. NAFLD is marked by the accumulation of fat and inflammation in the liver. The disease is …
More -
Latest Japanese NMN Kidney Study Indicates Kidney Damage Prevention and Function Restoration
Supplementing mice with nicotinamide mononucleotide benefits kidney function and corrects damage by activating longevity-promoting enzymes. When NMN is administered to mice suffering from kidney disease, it decreases the lesions on kidney tissue and reinstates podocytes which are essential kidney cells responsible for waste filtration. NMN supplementation activates an enzyme that promotes long-term health, Sirtuin-1, to …
More